$GILD Recent News Nasdaq slumps 1.2%, but Dow dips just

New Post Public Reply Private Reply Replies (0) Message Board

Mar 25, 2014 at 9:52 AM

$GILD Recent News

Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has a second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
Newscast: Stocks close lower after late fade 4:26 p.m. March 21, 2014 - MarketWatch
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Picking stocks to weather any market 1:15 p.m. March 21, 2014 - Mark Hulbert
The Nasdaq has a message to deliver 1:56 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt

Biotech Sell-Off Brings Value To U.S. Healthcare Stocks 8:08 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: Stay Far Away From Boardwalk Partners 6:00 a.m. Today - TheStreet.com
Stick to Buying on Weakness Unless This Happens 9:58 p.m. March 24, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Enemy Is Us 8:14 p.m. March 24, 2014 - TheStreet.com
Trading Winds Blow Cold for Some Hot Stocks 7:17 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
Top Industry Groups Take Big Hits In Market Sell-Off 4:56 p.m. March 24, 2014 - Investors Business Daily
Gilead Down on Sovaldi Price Issue - Analyst Blog 4:45 p.m. March 24, 2014 - Zacks.com
Are Biotech Stocks Oversold? - Analyst Blog 4:26 p.m. March 24, 2014 - Zacks.com
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him. 4:17 p.m. March 24, 2014 - TheStreet.com
Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline 4:14 p.m. March 24, 2014 - TheStreet.com
GILD, BIB, Others: How Worried Are Market-Makers About 'Government Pricing?' 3:14 p.m. March 24, 2014 - Seeking Alpha
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary 2:00 p.m. March 24, 2014 - Zacks.com
A Bubble Burst? Momentum Names Are Falling Hard 1:48 p.m. March 24, 2014 - Seeking Alpha
Sovaldi's Patent War 1:04 p.m. March 24, 2014 - Seeking Alpha
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates 11:21 a.m. March 24, 2014 - TheStreet.com
Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD 11:06 a.m. March 24, 2014 - GuruFocus.com
Why Gilead Sciences (GILD) Shares Are Lower Today 10:55 a.m. March 24, 2014 - TheStreet.com
Weekly CFO Sells Highlight: Google Inc., Facebook Inc., Gilead Sciences Inc. ... 10:54 a.m. March 24, 2014 - GuruFocus.com

Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 8:00 a.m. March 24, 2014 - PR Newswire - PRF
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case 7:01 a.m. March 24, 2014 - GlobeNewswire
Gilead Sciences Prices Hepatitis C Drug at $84,000; Versartis Commences Trading on the NASDAQ 12:30 a.m. March 24, 2014 - ACCESSWIRE
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...